249 related articles for article (PubMed ID: 20197760)
1. Relative roles of HBsAg seroclearance and mortality in the decline of HBsAg prevalence with increasing age.
Tai DI; Tsay PK; Chen WT; Chu CM; Liaw YF
Am J Gastroenterol; 2010 May; 105(5):1102-9. PubMed ID: 20197760
[TBL] [Abstract][Full Text] [Related]
2. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.
Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Wang LY; You SL; Iloeje UH; Chen CJ;
Gastroenterology; 2010 Aug; 139(2):474-82. PubMed ID: 20434450
[TBL] [Abstract][Full Text] [Related]
3. Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients.
Kwak MS; Cho EJ; Jang ES; Lee JH; Yu SJ; Kim YJ; Yoon JH; Lee HS
Digestion; 2011; 84 Suppl 1():23-8. PubMed ID: 22156482
[TBL] [Abstract][Full Text] [Related]
4. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
5. Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance.
Arai M; Togo S; Kanda T; Fujiwara K; Imazeki F; Yokosuka O
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):414-8. PubMed ID: 22273987
[TBL] [Abstract][Full Text] [Related]
6. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.
Yuen MF; Wong DK; Sablon E; Tse E; Ng IO; Yuan HJ; Siu CW; Sander TJ; Bourne EJ; Hall JG; Condreay LD; Lai CL
Hepatology; 2004 Jun; 39(6):1694-701. PubMed ID: 15185311
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
Am J Med; 2006 Jan; 119(1):71.e9-16. PubMed ID: 16431195
[TBL] [Abstract][Full Text] [Related]
8. Incidence and determinants of spontaneous seroclearance of hepatitis B e antigen and DNA in patients with chronic hepatitis B.
Yang HI; Hung HL; Lee MH; Liu J; Jen CL; Su J; Wang LY; Lu SN; You SL; Iloeje UH; Chen CJ;
Clin Gastroenterol Hepatol; 2012 May; 10(5):527-34.e1-2. PubMed ID: 22178461
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
10. Risk and predictors of mortality associated with chronic hepatitis B infection.
Iloeje UH; Yang HI; Jen CL; Su J; Wang LY; You SL; Chen CJ;
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):921-31. PubMed ID: 17678844
[TBL] [Abstract][Full Text] [Related]
11. Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection.
Chen YC; Jeng WJ; Chu CM; Liaw YF
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):297-302. PubMed ID: 21893131
[TBL] [Abstract][Full Text] [Related]
12. Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?
Chu CM; Lin DY; Liaw YF
Int J Obes (Lond); 2007 May; 31(5):871-5. PubMed ID: 17047638
[TBL] [Abstract][Full Text] [Related]
13. Distinct seromarkers predict different milestones of chronic hepatitis B progression.
Liu J; Yang HI; Lee MH; Batrla-Utermann R; Jen CL; Lu SN; Wang LY; You SL; Hsiao CK; Chen CJ;
Hepatology; 2014 Jul; 60(1):77-86. PubMed ID: 24700432
[TBL] [Abstract][Full Text] [Related]
14. Mortality after chronic hepatitis B virus infection: a linkage study involving 2 million parous women from Taiwan.
Fwu CW; Chien YC; Nelson KE; Kirk GD; You SL; Kuo HS; Feinleib M; Chen CJ
J Infect Dis; 2010 Apr; 201(7):1016-23. PubMed ID: 20187745
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.
Ruan P; Xu SY; Zhou BP; Huang J; Gong ZJ
J Int Med Res; 2013 Oct; 41(5):1732-9. PubMed ID: 23908397
[TBL] [Abstract][Full Text] [Related]
16. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
[TBL] [Abstract][Full Text] [Related]
17. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
Yalçin K; Değertekin H; Alp MN; Tekeş S; Satici O; Budak T
Turk J Gastroenterol; 2003 Sep; 14(3):157-63. PubMed ID: 14655057
[TBL] [Abstract][Full Text] [Related]
18. Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients.
Chan HL; Wong GL; Tse CH; Chan HY; Wong VW
J Infect Dis; 2011 Aug; 204(3):408-14. PubMed ID: 21742839
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
[TBL] [Abstract][Full Text] [Related]
20. A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection.
Liu J; Lee MH; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; Wang LY; You SL; Hsiao CK; Yang HI; Chen CJ
J Hepatol; 2013 May; 58(5):853-60. PubMed ID: 23246508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
